Business
PharmAust Receives $406K R&D Rebate from ATO
PharmAust Receives $406K R&D Rebate from ATO
About this update from Neurizon Therapeutics Limited
[{"type":"text","content":"Neurizon Therapeutics Limited has released a press release. View Attachment","length":250,"tagName":"div"}]